
Article
TB-500 vs BPC-157: What Tendon Research Can’t Settle
When a tendon injury lingers, it is natural to look for a clearer answer. The published comparison between these peptides is far narrower than online discussion suggests.
Read article
Article
When a tendon injury lingers, it is natural to look for a clearer answer. The published comparison between these peptides is far narrower than online discussion suggests.
Read article
Article
When body composition changes in midlife, similar-sounding growth-hormone peptides can look interchangeable. Their human research tells a much narrower story.
Read article
Article
When energy and exercise capacity feel different in midlife, mitochondrial claims can sound appealing. The MOTS-c record offers an interesting biology lesson, but not a human ranking.
Read article
Article
Longevity claims often travel faster than the studies behind them. Here is what direct Epithalon research measured, what it did not, and how Health Canada views injectable products.
Read article
Article
When concentration feels less reliable, it is tempting to look for a clear front-runner. The published human record on Semax and Selank does not yet provide one.
Read article
Article
A historic Canadian authorization and a cancelled DIN can sound contradictory. Here is what the record says, alongside the human trials that made tesamorelin worth studying.
Read article
Article
GHK-Cu is being studied for skin wound closure, but the strongest current answer is about measurement, not proven outcomes. Here is what human and lab studies actually show.
Read article
Article
Insulin sensitivity is a useful metabolic signal, but MOTS-c research is still mostly animal work and human biomarker studies.
Read article